Thursday, 11 December 2025
  
Login

Australia's most trusted
source of pharma news

Thursday, 11 December 2025
IQVIA
IQVIA
Pharma mood 'deeply pessimistic'

A new pharma sentiment index has exposed a "deeply pessimistic mood" across the industry as it tries to forge a path forward through one of the most difficult times in decades.

Judge protects $74M J&J market
Generics company will need to clear the way before launching PBAC-recommended drug on the PBS
TODAY
Pfizer unveils new obesity play
Hot on the heels of last month's drama-filled obesity buy, Pfizer has made another deal, this time for an oral GLP-1
TODAY
Unprecedented pharma burnout
Smaller teams, heavy workloads and gruelling work hours are leaving almost no time for wellbeing, leading to burnout
10 December
Aussie jobs go in latest cost-cutting
Ongoing global belt-tightening at this Big Pharma has hit Australia with yet more jobs being lost from the ANZ sector
9 December
Top speed launch of first generic
From ARTG to pharmacy shelves in under a month, Arrotex has wasted no time launching generic competition to this GSK drug
9 December
Ex-Aussie GM writing tell-all book
Despite reaching career heights most pharma executives can only dream of, this boss offers a reality check about the meaning of success
8 December
PiF survey
PiF survey
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (13)

Clinical & Medical, R&D (10)

Regulatory, Pharmacovigilance & QA (3)

Devices (1)

Executive Roles (4)

Other (12)

Pharma boss wins business award
High-profile leader has been named Business Person of the Year for his strategic deal-making and willingness to take risks
10 December
Keys to building a great culture
There are three key features to developing a great culture where pharma professionals would love to work, industry exec tells
10 December
Aussies land $558M licensing deal
Indian generics giant has signed a deal with an Australian biotech as part of its plan to break into the innovative medicines market
10 December
Local coders drive JAK discovery
Aussie computational drug discovery company behind a targeted JAK inhibitor without the side effects of TGA-ticked meds
10 December
Who's won an Aussie export gong?
Clinical trials company takes home its second prestigious award this year after rocketing sales in international markets
9 December
Vaccine probe uncovers flaws
Audit Office scrutinises Govt deals with Seqirus and Moderna, with one failing to maximise value for money for taxpayers
9 December
Data justifies hefty drug price tag
New data shows long-term durability of an expensive gene-therapy recently recommended for funding. Next, convince the Govt
9 December
Is ANZ Pharma ready for 2026?
Disruption across pharma will heighten in 2026. Are leaders ready? We're asking professionals from across the industry to take this survey
8 December
New data paves way for MSAC win
Pfizer announces impressive phase 3 results for its new haemophilia treatment which is under review by the MSAC
8 December
MSD tries again for broad listing
Company takes another crack at a multi-cancer recommendation alongside other submissions at PBAC's Dec Intracycle Meeting
8 December
$48 million market sees first threat
First generic of a diabetes drug has been registered on the ARTG, while competition for a cancer drug heats up
8 December Approvals Action
$130K fine for Aussie Code breach
Committee rules company material to be "misleading" after complaints from a rival, with an additional penalty for failing on Appeal
5 December
TGA considers $4M treatment
The single shot gene therapy could reduce uptake of competitor drugs used for the disease which earn $100M annually on the PBS
5 December
Meet ANZ's newest Country bosses
ICYMI: Three companies are going into 2026 with new bosses at the helm plus the other most popular stories this week
5 December Your Week in 5 Minutes
PiF Christimas
PiF Christimas
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.